Skip to main content

Featured

More HZMB private car quotas set

The governments of Hong Kong and Macau have agreed to increase the regular quotas for Hong Kong cross-boundary non-commercial private cars using the Hong Kong-Zhuhai-Macao Bridge to Macau, the Transport Department announced today.   The decision was made to enhance traffic flow between Hong Kong and Macau, better utilising the bridge, the department said.   It will increase the Hong Kong quota by 1,000, following the earlier quota allocation of 1,800 for Hong Kong.   The additional quota will be distributed in two phases from the second quarter.   Half of the additional 1,000 quota allocations is for company applicants and the other half is for individual applicants. The quotas are valid for no more than three years. The eligibility criteria of quota applications remains the same.   Private cars allocated with Hong Kong quotas will be permitted to access the city of Macau multiple times using the bridge.   The Hong Kong quota allotments will be re-allocated upon expiry thro

1 vaccination case reported

The Department of Health said as at 4pm today, in the past 24 hours it received one report from the Hospital Authority regarding a case admitted to the intensive care unit (ICU) with a suspected serious adverse event following COVID-19 vaccination.   The case involves a 51-year-old man who has history of diabetes, hypertension and hyperlipidaemia.   The patient had experienced shortness of breath since March 6 with a cough and sputum. He attended the accident and emergency department at Queen Elizabeth Hospital yesterday for treatment.   He was hospitalised with a provisional diagnosis of acute myocardial infarction and was admitted to the ICU last night for further treatment. He is in a critical condition.   The man received a dose of the CoronaVac COVID-19 vaccine at Yuen Wo Road Sports Centre Community Vaccination Centre on March 3.   The department said it immediately contacted the authority to obtain more information for investigation and assessment.   It will pass the case to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization for causality assessment, and the assessment result will be released.   According to the vaccine's product information, patients with uncontrolled severe chronic diseases should not be given the vaccine.   For patients with acute diseases, acute exacerbation of chronic diseases, severe chronic diseases, atopy and fever, the vaccine should be used with caution. They should delay vaccination until after a doctor's evaluation if necessary.
http://dlvr.it/RvHmXx

Popular Posts